CCR2 and CXCR4 regulate peripheral blood monocyte pharmacodynamics and link to efficacy in experimental autoimmune encephalomyelitis
Authors:
Open Access
- 11 November 2009
- journal article
- Published by Springer Nature in Journal of Inflammation
- Vol. 6 (1) , 32
Abstract
Background: CCR2 plays a key role in regulating monocyte trafficking to sites of inflammation and therefore has been the focus of much interest as a target for inflammatory disease. Methods: Here we examined the effects of CCR2 blockade with a potent small molecule antagonist to determine the pharmacodynamic consequences on the peripheral blood monocyte compartment in the context of acute and chronic inflammatory processes. Results: We demonstrate that CCR2 antagonism in vivo led to a rapid decrease in the number of circulating Ly6Chi monocytes and that this decrease was largely due to the CXCR4-dependent sequestration of these cells in the bone marrow, providing pharmacological evidence for a mechanism by which monocyte dynamics are regulated in vivo. CCR2 antagonism led to an accumulation of circulating CCL2 and CCL7 levels in the blood, indicating a role for CCR2 in regulating the levels of its ligands under homeostatic conditions. Finally, we show that the pharmacodynamic changes due to CCR2 antagonism were apparent after chronic dosing in mouse experimental autoimmune encephalomyelitis, a model in which CCR2 blockade demonstrated a dramatic reduction in disease severity, manifest in a reduced accumulation of monocytes and other cells in the CNS. Conclusion: CCR2 antagonism in vivo has tractable pharmacodynamic effects that can be used to align target engagement with biologic effects on disease activity.Keywords
This publication has 19 references indexed in Scilit:
- Pharmacological Characterization of Sch527123, a Potent Allosteric CXCR1/CXCR2 AntagonistThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sitesJournal of Clinical Investigation, 2007
- The Many Roles of Chemokines and Chemokine Receptors in InflammationNew England Journal of Medicine, 2006
- Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2Nature Immunology, 2006
- Discovery and Pharmacological Characterization of a Novel Rodent-Active CCR2 Antagonist, INCB3344The Journal of Immunology, 2005
- Chemokines Acting via CXCR2 and CXCR4 Control the Release of Neutrophils from the Bone Marrow and Their Return following SenescenceImmunity, 2003
- Blood Monocytes Consist of Two Principal Subsets with Distinct Migratory PropertiesImmunity, 2003
- Chemokines and diseaseNature Immunology, 2001
- Cc Chemokine Receptor 2 Is Critical for Induction of Experimental Autoimmune EncephalomyelitisJournal of Experimental Medicine, 2000
- The Chemokine Receptor CXCR4 Is Required for the Retention of B Lineage and Granulocytic Precursors within the Bone Marrow MicroenvironmentImmunity, 1999